长期COVID和可能的预防选择
1University Pharmacy Department of Pharmacy Administration, Faculty of Pharmaceutical Sciences, Semmelweis University, Hőgyes Endre U. 7-9., Budapest, 1092, Hungary.
Inflammopharmacology
|June 21, 2023
概括
长期COVID,影响10-20%的个人后COVID-19,呈现不同的症状. 了解其机制和风险因素对于有效的预防和治疗策略至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 大约10-20%的COVID-19幸存者经历了持续的,多样化的症状,这种情况被称为长期COVID.
- 长期COVID的发展可能与最初的急性疾病的严重程度有关.
- 确定的风险因素包括住院,ICU入院,晚年,女性性别和先前存在的并发症.
研究的目的:
- 为了探索长期COVID综合征的多面性质.
- 审查当前对长期COVID风险因素和潜在预防措施的理解.
- 突出正在进行的研究长期COVID机制和治疗干预措施.
主要方法:
- 关于长期COVID流行,风险因素和管理研究的文献综述.
- 对疫苗接种和抗病毒治疗对长期COVID发展的影响数据的分析.
- 对正在进行的长期COVID疗法临床试验的审查.
主要成果:
- 疫苗接种有望降低长期COVID风险,尽管保护可能是局部的.
- 口服抗病毒药物如Paxlovid和molnupiravir可以通过减轻严重的急性疾病来减少长期COVID的发生率.
- 许多临床试验正在调查饮食补充剂和各种药物用于长期COVID治疗.
结论:
- 对长期COVID的精确机制和风险因素的进一步研究是必不可少的.
- 阐明这些因素将为成功的长期COVID的预防和治疗策略铺平道路.
- 全面了解是管理COVID-19这种后急性后续的关键.
相关概念视频
01:28Pulmonary Tuberculosis V
214
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
01:26COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:20COPD: Pathogenesis and Clinical Features
365
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
365
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K